There's a lot of words used like "often" in that article when referencing cure that are too general in nature IMHO. It's great progress but as others have said, testing in mice vs humans often has very different results. Fingers crossed that these types of treatment approaches are the wave of the future, but they're not here quite yet. I'm certain hiccups will occur in humans that require further research, due diligences, testing and trials. I'm hopeful for my two sons, who are likely to face PCa at some point later in their lives, will have options like this with minimal side effect profiles, that I didn't have myself. I'm also hopeful that if I have to face recurrence or secondary cancers from my primary RT treatment, that options like this will be available by that point in time.
Warm Regards-CJ-age 46
Dx 11/13@42YO - PSA 5.8, -DRE, GS6, MPMRI G-Bx@JH - 1/12 cores+@<5% - AS started
11/14@43YO - NIH T3 ERC-MPMRI, PSA 5.84, PSA-D 0.127
5/15@43YO - Bx, -DRE, PSA 6.41, 6/18 cores+, unilateral all G6@<5-75%
2/16 - HDB-m@FCCC, PSA 6.6, stage T1C
PSA - 6.6 2/16, 6.0 8/16, 2.0 2/17, 8/17 0.8My Story